SciencePharma

About SciencePharma

SciencePharma is well-known since 2004, private company specializing in consulting services for pharmaceutical industry. We have realized hundreds of projects (EU and non-EU). We can advise on all aspects of CMC development, including stability study design to clinical and non-clinical trials. Clinical trials designed by our experts have ended up with positive registration process or Rx ...

  • PL
  • 2018
    On CPHI since
  • 100 - 249
    Employees
Company types
Consultancy
Contract Research Organisation (CRO)
Contract Service
Primary activities
Chemical Development
Clinical Research
Contract Research Organisation
Medical Devices
Other
Regulatory Affairs
Contact info

Products from SciencePharma (3)

  • CONSULTING SERVICES

    Product CONSULTING SERVICES

    SciencePharma is a leading, highly experienced consultancy company providing state-of-the-art services in a field of nonclinical and clinical studies. We gather a qualified team of experts, who carry‑out tasks from the various stages of projects/studies. As the consultancy company we deal with diversity is...
  • PHARMACOVIGILANCE

    Product PHARMACOVIGILANCE

    SciencePharma has developed full Pharmacovigilance system as described in Good Pharmacovigilance Practices (GVP) including all quality aspects and offers it to clients. We offer a comprehensive or partial services in the field of Pharmacovigilance.Our experienced, eager for knowled...
  • BOTULINUM NEUROTOXINS TYPE A AND B

    Product BOTULINUM NEUROTOXINS TYPE A AND B

    SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o., would like to kindly invite to negotiate rights acquisition to the documentation of development of the method for the production and purification of botulinum neurotoxins type A and B.
    The project was carried out within Ope...

SciencePharma Resources (2)

  • News BOTULINUM NEUROTOXINS TYPE A AND B

    SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o., would like to kindly invite you to negotiate rights acquisition to the documentation of development of the method for the production and purification of botulinum neurotoxins type A and B.
    The project was carried out within Operational Programme Innovative Economy 2007-2013, Action 1.4 “Support for special projects” based on co-financing agreement  POIG.01.04.00-14-008/13. In attachment you can find detailed description of this project.
  • Brochure REGULATORY AFFAIRS SERVICES

    SciencePharma offers multidisciplinary services covering all aspects of regulatory affairs including pre-authorisation, post-authorisation as well as handling of registration process of medicinal products (human/veterinary) and medical devices across all application types and various pharmaceutical forms. We can also support you in placing dietary supplements or cosmetics on a market.